Effect of Quinapril on In-Stent Restenosis and Relation to Plasma Apoptosis Signaling Molecules-Reference-Cited by-同舟云学术

Effect of Quinapril on In-Stent Restenosis and Relation to Plasma Apoptosis Signaling Molecules

Published:2010-01 Issue:1 Volume:105 Page:54-58
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Deftereos Spyridon,Giannopoulos Georgios,Kossyvakis Charalampos,Kaoukis Andreas,Raisakis Konstantin,Driva Metaxia,Panagopoulou Vasiliki,Lappos Spyridon,Rentoukas Ilias,Pyrgakis Vlasios,Alpert Martin A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study;Hoffman;Circulation,1996

2. The role of Fas/APO-1 and apoptosis in the development of human atherosclerotic lesions;Cai;Atherosclerosis,1997

3. Fas ligand gene therapy for vascular intimal hyperplasia;Jiang;Curr Gene Ther,2004

4. ACE-inhibition promotes apoptosis after balloon injury of rat carotid arteries;Holm;Cardivasc Res,2000

5. The Fas death factor;Nagata;Science,1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healed neointima of in-stent restenosis lesions in patients with stable angina pectoris: an intracoronary optical coherence tomography study;Heart and Vessels;2022-01-15

2. RAS inhibition in resident fibroblast biology;Cellular Signalling;2021-04

3. ACE Inhibitors Versus ARBs in Patients With NSTEMI With Preserved LV Systolic Function Who Underwent PCI With New Generation Drug-Eluting Stents;Angiology;2019-11-06

4. Long-term clinical outcome between beta-blocker with ACEI or ARB in patients with NSTEMI who underwent PCI with drug-eluting stents;J GERIATR CARDIOL;2019

5. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention;Atherosclerosis;2018-10